Increased extracellular volume in the liver of pediatric Fontan patients

Charlotte de Lange1,2, Marjolein J E Reichert1, Joseph J Pagano3

  • 1Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, University of Toronto, Ontario, Canada.

Insights

Pediatric patients with single ventricle conditions show elevated liver fibrosis markers, including native T1 and extracellular volume fraction (ECV), detected via cardiovascular magnetic resonance (CMR). These changes suggest liver fibrosis or congestion, even in young patients.

Area of Science:

  • Cardiovascular Imaging
  • Pediatric Cardiology
  • Hepatology

Background:

  • Single ventricle physiology places patients at high risk for liver fibrosis.
  • The prevalence and extent of liver fibrosis in children with bidirectional cavopulmonary connection (BCPC) and Fontan circulation are not well-established.
  • Cardiovascular magnetic resonance (CMR) T1 relaxometry and extracellular volume fraction (ECV) can indicate liver fibrotic remodeling and congestion.

Purpose of the Study:

  • To investigate elevated native T1 and ECV in pediatric patients with single ventricle physiology.
  • To assess these as potential markers for liver fibrosis and/or congestion.

Main Methods:

  • Retrospective analysis of hepatic native T1 times and ECV using cardiac MRI.
  • Comparison between children with BCPC and Fontan circulations and healthy pediatric controls.

Main Results:

  • Fontan patients exhibited higher native T1 times compared to BCPC patients and controls (p < 0.001).
  • ECV was significantly higher in Fontan patients (41.4%) than BCPC patients (36.4%, p=0.02).
  • In Fontan patients, T1 correlated with cardiopulmonary bypass time and ventricular volumes, and inversely with oxygen saturation and body surface area.

Conclusions:

  • Patients with Fontan and BCPC circulations demonstrate elevated CMR-derived markers indicative of hepatic fibrosis and/or congestion.
  • These liver tissue changes are detectable even in young patients.
  • Central venous pressure was not associated with these observed T1 or ECV changes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.5K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.1K